Europe — EMA
Orfiril (Sodium Valproate)
Sodium Valproate, the active ingredient in Orfiril, is an anticonvulsant presented as a tablet for oral use. It is used to treat seizure disorders and is prescribed for both adult and pediatric patients.
Request sourcing
What is Sodium Valproate?
Sodium Valproate, the active ingredient in Orfiril, is an anticonvulsant presented as a tablet for oral use. It is used to treat seizure disorders and is prescribed for both adult and pediatric patients. GNH USA supplies Orfiril as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
GNH USA supplies Orfiril as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.
What is Sodium Valproate used for?
Orfiril is an anticonvulsant that acts on neuronal excitability in various seizure disorders.
- Epilepsy: Reduces the frequency and severity of generalized tonic‑clonic seizures. - Bipolar disorder: Stabilises mood and helps prevent manic episodes. - Migraine prophylaxis: Decreases the occurrence of migraine attacks. - Trigeminal neuralgia: Alleviates neuropathic facial pain associated with the condition. - Status ‑ t t t
What are the side effects of Sodium Valproate?
The … t ...
What precautions apply to Sodium Valproate?
…
